Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

SIM01 significantly reduced post-COVID symptoms and is safe.

A woman's hair loss improved with treatment after a COVID-19 infection.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

Long COVID causes various long-term health issues and needs better awareness and treatment.

A man with a rare lung-focused form of hypereosinophilic syndrome improved with steroid treatment.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

More research is needed to understand how testosterone is maintained in adult males.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.